Follow the people · Insider
riley mccormack
riley mccormack files insider transactions with the SEC as a chief executive officer of Digimarc Parent (DMRC). We hold 3 disclosed purchases and sales filed since 4 February 2014, 3 of them in the last 90 days.
- Files forDMRC
- Disclosed buys and sells3 in all, 3 in the last 90 days
- Last disclosure7 July 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 27 October 2020 — 5 July 2026Chief Executive Officer · Digimarc Parent (DMRC)20 Form 4 lines · source: SEC Form 4
- Filed 4 February 2014 — 16 January 201510% owner · ARCA biopharma (ABIO)8 Form 4 lines · source: SEC Form 4
Everything they disclosed
28 entries, newest first — one per disclosure report, one per Form 4 line- was granted 64,146 shares of DigimarcSEC Form 47 July 2026Common Stock · traded 5 July 2026 · filed 7 July 2026
- acquired or disposed of, other 2,275,737 shares of DigimarcSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 69,363 shares of DigimarcSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 3,512 shares of DigimarcSEC Form 418 June 2026Common Stock · traded 16 June 2026 · filed 18 June 2026
- ▼ sold on the open market 15,003 shares of DigimarcSEC Form 418 June 2026Common Stock · traded 17 June 2026 · filed 18 June 2026
- ▼ sold on the open market 27,071 shares of DigimarcSEC Form 418 June 2026Common Stock · traded 18 June 2026 · filed 18 June 2026
- was granted 500 shares of Digimarc (a derivative holding)SEC Form 421 May 2026Unit Option · traded 21 May 2026 · filed 21 May 2026
- exercised options over 500 shares of Digimarc (a derivative holding)SEC Form 421 May 2026Unit Option · traded 21 May 2026 · filed 21 May 2026
- was granted 500 shares of Digimarc (a derivative holding)SEC Form 421 May 2026Common Units · traded 21 May 2026 · filed 21 May 2026
- was granted 5,103 shares of Digimarc Parent (a derivative holding)SEC Form 420 May 2026Common Units · traded 19 May 2026 · filed 20 May 2026
- was granted 1,050,000 shares of Digimarc Parent (a derivative holding)SEC Form 420 May 2026Long-Term Incentive Plan Units · traded 19 May 2026 · filed 20 May 2026
- was granted 18,160 shares of DigimarcSEC Form 419 February 2025Common Stock · traded 15 February 2025 · filed 19 February 2025
- was granted 1,309 shares of DigimarcSEC Form 417 February 2023Common Stock · traded 15 February 2023 · filed 17 February 2023
- ▲ bought on the open market 18,347 shares of DigimarcSEC Form 410 March 2022Common Stock · traded 8 March 2022 · filed 10 March 2022
- ▲ bought on the open market 1,653 shares of DigimarcSEC Form 410 March 2022Common Stock · traded 8 March 2022 · filed 10 March 2022
- ▲ bought on the open market 9,199 shares of DigimarcSEC Form 410 March 2022Common Stock · traded 9 March 2022 · filed 10 March 2022
- ▲ bought on the open market 801 shares of DigimarcSEC Form 410 March 2022Common Stock · traded 9 March 2022 · filed 10 March 2022
- was granted 8,644 shares of DigimarcSEC Form 428 June 2021Common Stock · traded 12 April 2021 · filed 28 June 2021
- was granted 8,644 shares of DigimarcSEC Form 414 April 2021Common Stock · traded 12 April 2021 · filed 14 April 2021
- was granted 6,546 shares of DigimarcSEC Form 430 October 2020Common Stock · traded 27 October 2020 · filed 30 October 2020
- ▼ sold on the open market 125,000 shares of ARCA biopharmaSEC Form 416 January 2015COMMON STOCK · traded 14 January 2015 · filed 16 January 2015
- ▼ sold on the open market 125,000 shares of ARCA biopharmaSEC Form 416 January 2015COMMON STOCK · traded 15 January 2015 · filed 16 January 2015
- ▼ sold on the open market 100,000 shares of ARCA biopharmaSEC Form 416 January 2015COMMON STOCK · traded 16 January 2015 · filed 16 January 2015
- ▼ sold on the open market 150,000 shares of ARCA biopharmaSEC Form 47 January 2015COMMON STOCK · traded 5 January 2015 · filed 7 January 2015
- ▼ sold on the open market 200,000 shares of ARCA biopharmaSEC Form 47 January 2015COMMON STOCK · traded 6 January 2015 · filed 7 January 2015
- ▼ sold on the open market 200,000 shares of ARCA biopharmaSEC Form 47 January 2015COMMON STOCK · traded 7 January 2015 · filed 7 January 2015
- ▲ bought on the open market 1,000,000 shares of ARCA biopharmaSEC Form 44 February 2014COMMON STOCK · traded 4 February 2014 · filed 4 February 2014
- ▲ bought on the open market 250,000 shares of ARCA biopharma (a derivative holding)SEC Form 44 February 2014Warrant to purchase common stock · traded 4 February 2014 · filed 4 February 2014
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.